drugset / Press release
Lipum has entered a partnership with QPS Netherlands B.V. for its first clinical trial with SOL-116
2022-03-09 · Lipum AB · original lipum.se ↗
Press release: Umeå, March 9, 2022. Lipum AB (publ) announce that the company has entered into an agreement with QPS Netherlands BV for the first-in-man phase I-study of the drug candidate SOL-116.
The release as fetched from its publisher. lipum.se ↗